Delafloxacin meglumine Inhibitor

MBS5758994 is an inhibitor targeting Delafloxacin meglumine. Delafloxacin meglumine is a broad-spectrum fluoroquinolone antibiotic

Lepak AJ, et al. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model. Antimicrob Agents Chemother. 2016 Jul 22;60(8):4764-9.
Lepak AJ, et al. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model. Antimicrob Agents Chemother. 2016 Jul 22;60(8):4764-9.
Mogle, Bryan, T,et al. Clinical review of delafloxacin: a novel anionic fluoroquinolone[J]. Journal of Antimicrobial Chemotherapy, 2018.
Gena K, Kapoor E, Dasgupta A, et al. Delafloxacin meglumine for the treatment,of acute bacterial skin and skin structure infections (ABSSSI).[J]. Drugs of Today, 2018, 54:pags. 657-666.

Small volumes of Delafloxacin meglumine, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.